Risk of Skin Cancer among Patients with Chronic Kidney Disease Treated with Ultraviolet B Phototherapy for Uraemic Pruritus: A Nationwide Cohort Study
DOI:
https://doi.org/10.2340/00015555-3758Keywords:
UVB phototherapy, skin cancer, uraemic pruritus, chronic kidney diseaseAbstract
The safety of ultraviolet B (UVB) phototherapy with respect to cutaneous carcinogenesis has not been established for patients with chronic kidney disease. To investigate this issue, a nationwide cohort study of 10,805 patients with advanced chronic kidney disease was conducted using data from the National Health Insurance of Taiwan, the Taiwan Cancer Registry, and the national death registry. After a median follow-up of 75 months, 16 of 2,161 patients in the UVB group and 63 of 8,644 patients in the non-UVB group developed skin cancers. Compared with the non-UVB group, patients in the UVB group did not show an increased risk of skin cancer (hazard ratio 1.066; 95% confidence interval 0.584–1.944), non-melanoma skin cancer (hazard ratio 1.067; 95% confidence interval 0.571–1.996), or cutaneous melanoma (hazard ratio 1.009; 95% confidence interval 0.115–8.879). In addition, patients who received more UVB phototherapy did not show an increased risk of skin cancer. UVB phototherapy appears to be a safe treatment for uraemic pruritus in patients with chronic kidney disease.
Downloads
References
Mettang T, Kremer AE. Uremic pruritus. Kidney Int 2015; 87: 685-691.
DOI: https://doi.org/10.1038/ki.2013.454
Wu HY, Huang JW, Tsai WC, Peng YS, Chen HY, Yang JY, et al. Prognostic importance and determinants of uremic pruritus in patients receiving peritoneal dialysis: a prospective cohort study. PLoS One 2018; 13: e0203474.
DOI: https://doi.org/10.1371/journal.pone.0203474
Wu HY, Peng YS, Chen HY, Tsai WC, Yang JY, Hsu SP, et al. A comparison of uremic pruritus in patients receiving peritoneal dialysis and hemodialysis. Medicine 2016; 95: e2935.
DOI: https://doi.org/10.1097/MD.0000000000002935
Tartar D, Bhutani T, Huynh M, Berger T, Koo J. Update on the immunological mechanism of action behind phototherapy. J Drugs Dermatol 2014; 13: 564-568.
Fallahzadeh MK, Roozbeh J, Geramizadeh B, Namazi MR. Interleukin-2 serum levels are elevated in patients with uremic pruritus: a novel finding with practical implications. Nephrol Dial Transplant 2011; 26: 3338-3344.
DOI: https://doi.org/10.1093/ndt/gfr053
Ko MJ, Peng YS, Chen HY, Hsu SP, Pai MF, Yang JY, et al. Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis. J Am Acad Dermatol 2014; 71: 1151-1159.
DOI: https://doi.org/10.1016/j.jaad.2014.08.004
Ko MJ, Yang JY, Wu HY, Hu FC, Chen SI, Tsai PJ, et al. Narrowband ultraviolet B phototherapy for patients with refractory uraemic pruritus: a randomized controlled trial. Br J Dermatol 2011; 165: 633-639.
DOI: https://doi.org/10.1111/j.1365-2133.2011.10448.x
Christensen L, Suggs A, Baron E. Ultraviolet photobiology in dermatology. Adv Exp Med Biol 2017; 996: 89-104.
DOI: https://doi.org/10.1007/978-3-319-56017-5_8
Stern RS, Liebman EJ, Vakeva L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA follow-up study. J Natl Cancer Inst 1998; 90: 1278-1284.
DOI: https://doi.org/10.1093/jnci/90.17.1278
Stern RS. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 2001; 44: 755-761.
DOI: https://doi.org/10.1067/mjd.2001.114576
Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maitre M, et al. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012; 26: 22-31.
DOI: https://doi.org/10.1111/j.1468-3083.2012.04520.x
Jo SJ, Kwon HH, Choi MR, Youn JI. No evidence for increased skin cancer risk in Koreans with skin phototypes III-V treated with narrowband UVB phototherapy. Acta Derm Venereol 2011; 91: 40-43.
DOI: https://doi.org/10.2340/00015555-0995
Weischer M, Blum A, Eberhard F, Rocken M, Berneburg M. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. Acta Derm Venereol 2004; 84: 370-374.
DOI: https://doi.org/10.1080/00015550410026948
Hearn RM, Kerr AC, Rahim KF, Ferguson J, Dawe RS. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol 2008; 159: 931-935.
DOI: https://doi.org/10.1111/j.1365-2133.2008.08776.x
Black RJ, Gavin AT. Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data. Br J Dermatol 2006; 154: 566-567.
DOI: https://doi.org/10.1111/j.1365-2133.2005.07085.x
Diffey BL, Farr PM. The challenge of follow-up in narrowband ultraviolet B phototherapy. Br J Dermatol 2007; 157: 344-349.
DOI: https://doi.org/10.1111/j.1365-2133.2007.07980.x
Wang CC, Tang CH, Huang SY, Huang KC, Sue YM. Risk of non-melanoma skin cancer in patients with chronic kidney disease and its relationship to uraemic pruritus. Acta Derm Venereol 2017; 97: 1230-1234.
DOI: https://doi.org/10.2340/00015555-2762
Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000; 355: 1886-1887.
DOI: https://doi.org/10.1016/S0140-6736(00)02298-4
Hsing AW, Ioannidis JP. Nationwide population science: lessons from the Taiwan National Health Insurance Research Database. JAMA Intern Med 2015; 175: 1527-1529.
DOI: https://doi.org/10.1001/jamainternmed.2015.3540
Wu HY, Fukuma S, Shimizu S, Norton EC, Tu YK, Hung KY, et al. Effects of higher quality of care on initiation of long-term dialysis in patients with CKD and diabetes. Am J Kidney Dis 2017; 70: 666-674.
DOI: https://doi.org/10.1053/j.ajkd.2017.05.020
Wu HY, Peng CL, Chen PC, Chiang CK, Chang CJ, Huang JW, et al. Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: a 15-year cohort study. PLoS One 2017; 12: e0177654.
DOI: https://doi.org/10.1371/journal.pone.0177654
Chiang CJ, You SL, Chen CJ, Yang YW, Lo WC, Lai MS. Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review. Jpn J Clin Oncol 2015; 45: 291-296.
DOI: https://doi.org/10.1093/jjco/hyu211
Chiang CJ, Lo WC, Yang YW, You SL, Chen CJ, Lai MS. Incidence and survival of adult cancer patients in Taiwan, 2002-2012. J Formos Med Assoc 2016; 115: 1076-1088.
DOI: https://doi.org/10.1016/j.jfma.2015.10.011
Yu HC, Lin CL, Chen ZT, Hu FR, Sung FC, Wang IJ. Risk of skin cancer in patients with pterygium: a nationwide population-based cohort study in Taiwan. Ocul Surf 2014; 12: 69-76.
DOI: https://doi.org/10.1016/j.jtos.2013.08.003
Lee KF, Tsai YT, Lin CY, Hsieh CB, Wu ST, Ke HY, et al. Cancer incidence among heart, kidney, and liver transplant recipients in Taiwan. PLoS One 2016; 11: e0155602.
DOI: https://doi.org/10.1371/journal.pone.0155602
Howard MD, Su JC, Chong AH. Skin cancer following solid organ transplantation: a review of risk factors and models of care. Am J Clin Dermatol 2018; 19: 585-597.
DOI: https://doi.org/10.1007/s40257-018-0355-8
Pedersen SA, Gaist D, Schmidt SAJ, Holmich LR, Friis S, Pottegard A. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: a nationwide case-control study from Denmark. J Am Acad Dermatol 2018; 78: 673-681.
DOI: https://doi.org/10.1016/j.jaad.2017.11.042
Eide MJ, Weinstock MA. Association of UV index, latitude, and melanoma incidence in nonwhite populations - US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001. Arch Dermatol 2005; 141: 477-481.
DOI: https://doi.org/10.1001/archderm.141.4.477
Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat-Simul C 2009; 38: 1228-1234.
DOI: https://doi.org/10.1080/03610910902859574
Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994; 81: 515-526.
DOI: https://doi.org/10.1093/biomet/81.3.515
Taylor HR. Aetiology of climatic droplet keratopathy and pterygium. Br J Ophthalmol 1980; 64: 154-163.
DOI: https://doi.org/10.1136/bjo.64.3.154
Pottegard A, Pedersen SA, Schmidt SAJ, Lee CN, Hsu CK, Liao TC, et al. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study. Br J Cancer 2019; 121: 973-978.
DOI: https://doi.org/10.1038/s41416-019-0613-4
Park E, Lee Y, Jue MS. Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea. Korean J Intern Med 2020; 35: 917-928.
DOI: https://doi.org/10.3904/kjim.2019.218
Friedman GD, Asgari MM, Warton EM, Chan J, Habel LA. Antihypertensive drugs and lip cancer in non-Hispanic whites. Arch Intern Med 2012; 172: 1246-1251.
DOI: https://doi.org/10.1001/archinternmed.2012.2754
Li YW, Chu CY. The minimal erythema dose of broadband ultraviolet B in Taiwanese. J Formos Med Assoc 2007; 106: 975-978.
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Mei-Ju Ko, Jenq-Wen Huang, Hon-Yen Wu, Wan-Chuan Tsai, Le-Yin Hsu, Ping-Hsiu Tsai, Kuo-Liong Chien, Kuan-Yu Hung
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
